Search

Search Results

• 

  New approved drugs for psoriatic arthritis

  F.M. Perrotta, E. Lubrano

  57-64

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.873

  3208

  PDF: 2244
• 

  Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies

  A. Notarnicola, G. Lapadula, D. Natuzzi, F. Iannone

  215-223

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.746

  1832

  PDF: 1215
• 

  Osteoporosis and rheumatic diseases

  N. Maruotti, A. Corrado, F.P. Cantatore

  125-135

  28-06-2014

  https://doi.org/10.4081/reumatismo.2014.785

  8323

  PDF: 3525
• 

  Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

  R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

  83-89

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.875

  1913

  PDF: 950

  IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 542
• 

  Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome

  P. Galozzi, O. Negm, E. Greco, N. Alkhattabi, A. Gava, P. Sfriso, L. Fairclough, I. Todd, P. Tighe, L. Punzi

  277-284

  31-03-2015

  https://doi.org/10.4081/reumatismo.2014.772

  2135

  PDF: 1023
• 

  Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis

  A. Lo Gullo, G. Mandraffino, C.O. Aragona, A. Molica Colella, A. Saitta, E. Imbalzano

  184-188

  21-12-2017

  https://doi.org/10.4081/reumatismo.2017.1013

  1539

  PDF: 861
• 

  The laboratory approach in the diagnosis of systemic autoinflammatory diseases

  L. Cantarini, D. Rigante, M.G. Brizi, G.D. Sebastiani, O.M. Lucherini, M. Galeazzi, B. Frediani

  101-110

  https://doi.org/10.4081/reumatismo.2011.101

  1583

  PDF: 1222
• 

  The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease

  Ennio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, Carla Felice, Fabio Massimo Perrotta, Vincenzo Venerito, Sergio Del Vescovo, Roberta Ramonda, Giulia Cassone, Fabiola Atzeni, Roberto Caporali, Fabrizio Conti, Elisa Gremese, Florenzo Iannone, Marco Sebastiani, Ennio Giulio Favalli

  11-11-2024

  https://doi.org/10.4081/reumatismo.2024.1688

  1730

  PDF: 334

• IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

  U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

  62-73

  https://doi.org/10.4081/reumatismo.2004.1s.62

  1318

  PDF: 1940
• 

  Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review

  Carlo Perricone, Roberto Dal Pozzolo, Giacomo Cafaro, Santina Calvacchi, Lorenza Bruno, Francesco Tromby, Anna Colangelo, Roberto Gerli, Elena Bartoloni

  25-10-2024

  https://doi.org/10.4081/reumatismo.2024.1685

  2000

  PDF: 410

• Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

  C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

  224-235

  https://doi.org/10.4081/reumatismo.2003.224

  1157

  PDF: 2601
• 

  Spa therapy induces clinical improvement and protein changes in patients with chronic back pain

  M.M. Angioni, A. Denotti, S. Pinna, C. Sanna, F. Montisci, G. Dessole, A. Loi, A. Cauli

  119-131

  24-10-2019

  https://doi.org/10.4081/reumatismo.2019.1200

  4754

  PDF: 2802
• 

  The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity

  W.A. Wan Asyraf, M.S. Mohd Shahrir, W. Asrul, A.W. Norasyikin, O. Hanita, W.Y. Kong, M.T. Azmi

  241-250

  20-12-2018

  https://doi.org/10.4081/reumatismo.2018.1075

  1668

  PDF: 1062
• 

  Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined

  L. Cantarini, A. Vitale, O.M. Lucherini, I. Muscari, F. Magnotti, G. Brizi, B. Frediani, G.D. Sebastiani, M. Galeazzi, D. Rigante

  55-62

  12-06-2013

  https://doi.org/10.4081/reumatismo.2013.55

  6422

  PDF: 1126

• PO:01:004 | Real-world retention of IL-17 inhibitors in psoriatic arthritis: impact of prior IL-17 exposure across multiple treatment lines in the “birra” multicentre cohort Valentino Paci¹, Alarico Ariani², Eleonora Celletti³, Alberto Lo Gullo⁴, Camilla Mazzanti⁵, Valeria Nucera⁶, Natalia Mansueto⁷, Rosalba Caccavale⁸, Patrizia Del Medico⁹, Antonella Farina¹⁰, Palma Scolieri¹¹, Cecilia Giampietro¹², Olga Addimanda¹³, Riccardo Bixio¹⁴, Maddalena Larosa¹⁵, Viviana Ravagnani¹⁶, Federica Lumetti¹⁷, Aldo Biagio Molica Colella¹⁷, Elena Bravi¹⁷, Rosetta Vitetta¹⁷, Bernd Raffeiner¹⁷, Gilda Sandri¹⁸, Rosario Foti¹⁹, Simone Parisi²⁰, Michele Maria Luchetti Gentiloni¹, Gianluca Moroncini¹. | ¹Clinical Medicine, Department of Clinical and Molecular Sciences, Marche Polytechnic University, AOU delle Marche, Ancona; ²Internal Medicine and Rheumatology Unit, University Hospital of Parma, Parma; ³Rheumatology Unit, Clinica Medica Institute, Ospedale SS. Annunziata di Chieti, G.d'Annunzio University of Chieti, Chieti; ⁴Rheumatology Unit, ARNAS Garibaldi di Catania, Catania; ⁵Center for the Diagnosis and Therapy of Autoimmune Rheumagological Diseases, Ospedale Santa Rosa, ASL Viterbo, Viterbo; ⁶Rheumatology Outpatient Unit, ASL Novara, Novara; ⁷Ambulatori di Reumatologia ASL1 Liguria, Imperia Hospitall, Imperia; ⁸Department of Clinical, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Polo Pontino, Roma; ⁹Rheumatology outpatient clinic - Internal Medicine Unit, Civitanova, Marche Hospital, Civitanova, Marche; ¹⁰Internal Medicine Unit, Rheumatology outpatient clinic, Ospedale A. Murri di Fermo Fermo; ¹¹Department of Medical Specialties, Nuovo Regina Margherita Hospital, Roma; ¹²Rheumatology Outpatient Clinic, Azienda ULSS 6 Euganea, Padova, Padova; ¹³Rheumatology Unit, Azienda Unità Sanitaria Locale di Bologna -- Policlinico S.Orsola- AOU di Bologna, Bologna; ¹⁴Rheumatology Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona; ¹⁵Division of Rheumatology - Medical Specialties Department, Ospedale La Colletta-Azienda Sanitaria Locale 3 Genova; ¹⁶Rheumatology Unit, Santa Chiara Hospital APSS Trento; ¹⁷BIRRA - BIologic Retention Rate in chronic Arthritis - study group Parma; ¹⁸Rheumatology Unit, University of Modena and Reggio Emilia, Modena; ¹⁹Rheumatology Unit, Policlinico San Marco Hospital, Catania; ²⁰Rheumatology Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

  PAGEPress Publications

  06-10-2025

  https://doi.org/10.4081/reumatismo.2025.1951

  17

• Anabolic effects and inhibition of interleukin 6 production induced by neridronate on human osteoblasts

  A. Spreafico, B. Frediani, C. Capperucci, D. Gambera, P. Ferrata, F. Baldi, F. Chellini, S. Niccolini, L. Bocchi, R. Marcolongo

  288-300

  https://doi.org/10.4081/reumatismo.2006.288

  1253

  PDF: 744